FK 506 in clinical kidney transplantation.

摘要: Early reports on the use of FK 506 after kidney transplantation emphasized ability to stop prednisone in a significant percentage successfully transplanted patients.1,2 In addition, there was relative freedom from antihypertensive agents and tendency toward low serum cholesterol levels. This report will summarize our experience date with renal compare results nearly concurrent group patients treated cyclosporine (CyA)-based immunosuppression.